benefit "treatment by a chief physician", you have the opportunity to be treated personally by Professor Dr. Schmelzle. In this case, your initial appointment will take place during the private consultation [...] accommodated in a single or double room in our modern transplant and private ward 85, if possible. Professor Schmelzle always performs his operations personally, assisted by his team of selected physicians [...] surgical treatment mission is more important than a patient's insurance status. For this reason, Professor Schmelzle and his team regularly treat patients who are not privately insured and who present to

CogniNMO study. A total of 17 treatment centers specialised in the disease in Germany took part. Professor Dr Corinna Trebst and Dr Martin Hümmert from the Department of Neurology at the Hannover Medical [...] been clear until now. Studies had delivered different and partly contradictory results on this," Professor Trebst describes the initial situation. Cognitive abilities are various processes that serve the [...] percent in at least two cognition tests, is much lower than assumed from previous studies," explains Professor Trebst. The cognitive impairments are not related to disease relapses or to the presence of an antibody

cells and immune cell preparations are playing an increasingly important role in modern medicine. Professor Dr. Nico Lachmann, research group leader at the Clinic for Paediatric Pneumology, Allergology and [...] different. "This is a major problem for the health industry and massively slows down innovation," Professor Lachmann points out. In order to meet the steadily growing demand, biomedical research is therefore [...] and drugs. Based on this key technology for the continuous production of macrophages from iPSC, Professor Lachmann's team also wants to develop new manufacturing processes for different fully standardised

or MMR gene variants were mainly affected by brain tumours but also other solid tumours," says Professor Christian Kratz, initiator of the study published in the Journal of the National Cancer Institute [...] such a variant in a healthy child would currently not justify any immediate medical consequences," Professor Kratz emphasises. "Our results therefore give no reason to change the current practice of predictive [...] treating a child with cancer and the type of follow-up care after treatment has been completed," says Professor Kratz. "The detection of BRCA1/2 or MMR gene variants in an affected child with cancer also offers

diagnosed AML. This was the result of an international clinical study with the participation of Professor Dr. Michael Heuser, Senior Physician at the Department of Haematology, Haemostaseology, Oncology [...] compounds in the mouse model a few years ago and observed significant synergistic effects," says Professor Heuser. In the clinical trial, the researchers were now also able to demonstrate this effect in [...] for patients for whom intensive chemotherapy to fight the tumour is out of the question," says Professor Heuser. Another advantage is that undesirable side effects such as infections, pneumonia or blood

says Professor Claus. Next, the research team therefore wants to investigate an improved therapy and search for further molecular switches. SERVICE: For further information , please contact Professor Dr [...] still unclear how exactly the loss of motor neurones occurs. An international research team led by Professor Dr. Peter Claus, molecular biologist at the Institute of Neuroanatomy and Cell Biology at the Hannover [...] switch that is important for processing certain molecular signals in the motor nerve cells," says Professor Claus. The switch is called B-Raf and is a linchpin of the disease. "As the centre of an extensive

the stem cells come from a donor person, i.e. a relative or an anonymous person. Clinic Director Professor Dr. Arnold Ganser is pleased about the record: "We were able to help many affected people, although [...] are leukaemias, i.e. blood cancers, or lymphomas, i.e. tumours in the lymphatic tissue," explains Professor Dr Matthias Eder, Vice Clinic Director. Stem cell transplantation is indicated, for example, when [...] right time. "It could be that the person in question has Corona or is in quarantine," explains Professor Eder. "Then we would have conditioned the patient or the patient and the urgently needed donor stem

outside on the weakened heart muscle. "This is a kind of gentle, permanent cardiac massage," explains Professor Dr. Arjang Ruhparwar, Director of the Clinic for Cardiac, Thoracic, Transplantation and Vascular [...] of the continuously running pumps, the pulsatility is maintained with this new device," explains Professor Arjang Ruhparwar, "moreover, it does not come into contact with the patient's blood. Patients don't [...] the new system for 45 minutes beforehand during the operation. The team from Great Britain led by Professor Stephan Schueler also came to Hanover for the first operation of this kind worldwide. In the meantime

tool in which all of this is stored and can be retrieved in a complete and structured way," says Professor Dr. Udo Bavendiek, senior physician at the Department of Cardiology and Angiology at the MHH, giving [...] want to record the risk parameters directly when patients take their medical history," explains Professor Bavendiek. Risk parameters for cardiovascular diseases include blood pressure, blood sugar, tobacco [...] easier for those treating the patient. "Less 'text work' means more time for patients," emphasizes Professor Bavendiek. However, the structured medical history also has advantages for patients. With the data

by Professor Dr Johann Bauersachs. "In heart failure, the weakened heart tries to compensate for its reduced pumping capacity by increasing muscle mass, i.e. by growing larger," explains Professor Wollert [...] the suspicion that the inflammation might also have its good side. Now, a research team led by Professor Dr. Kai Wollert, Head of Molecular and Translational Cardiology at the Department of Cardiology [...] inflammation must be considered when thinking about anti-inflammatory therapies for heart failure, Professor Wollert and his team emphasise. Moreover, the growth factor MYGDF could possibly be administered